IL103710A - R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivatives - Google Patents
R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivativesInfo
- Publication number
- IL103710A IL103710A IL103710A IL10371092A IL103710A IL 103710 A IL103710 A IL 103710A IL 103710 A IL103710 A IL 103710A IL 10371092 A IL10371092 A IL 10371092A IL 103710 A IL103710 A IL 103710A
- Authority
- IL
- Israel
- Prior art keywords
- oxo
- derivatives
- phosphononorvaline
- formula
- trityl
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 18
- OLCWOBHEVRCMLO-SCSAIBSYSA-N (2r)-2-amino-4-oxo-5-phosphonopentanoic acid Chemical class OC(=O)[C@H](N)CC(=O)CP(O)(O)=O OLCWOBHEVRCMLO-SCSAIBSYSA-N 0.000 claims description 15
- -1 (R)-4-oxo-5- phosphononorvaline ester Chemical class 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- VONWDASPFIQPDY-UHFFFAOYSA-N dimethyl methylphosphonate Chemical compound COP(C)(=O)OC VONWDASPFIQPDY-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- HYHXAZMLKDGXEI-JOCHJYFZSA-N dimethyl (2r)-2-(tritylamino)butanedioate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@H](CC(=O)OC)C(=O)OC)C1=CC=CC=C1 HYHXAZMLKDGXEI-JOCHJYFZSA-N 0.000 abstract description 7
- 239000005557 antagonist Substances 0.000 abstract description 6
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 9
- 239000000376 reactant Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- KGMHYPXNXMMYOA-FQEVSTJZSA-N (2s)-2-(tritylamino)butanedioic acid Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@@H](CC(=O)O)C(O)=O)C1=CC=CC=C1 KGMHYPXNXMMYOA-FQEVSTJZSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical group COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 2
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 2
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 238000004679 31P NMR spectroscopy Methods 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- UHWGJZCBDJVMDS-HSZRJFAPSA-N [(4r)-5-methoxy-2,5-dioxo-4-(tritylamino)pentyl]phosphonic acid Chemical class C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@H](CC(=O)CP(O)(O)=O)C(=O)OC)C1=CC=CC=C1 UHWGJZCBDJVMDS-HSZRJFAPSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003194 amino acid receptor blocking agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- YLFBFPXKTIQSSY-UHFFFAOYSA-N dimethoxy(oxo)phosphanium Chemical compound CO[P+](=O)OC YLFBFPXKTIQSSY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- HTSNHUZTPQKPCQ-RUZDIDTESA-N methyl (2r)-5-dimethoxyphosphoryl-4-oxo-2-(tritylamino)pentanoate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@H](CC(=O)CP(=O)(OC)OC)C(=O)OC)C1=CC=CC=C1 HTSNHUZTPQKPCQ-RUZDIDTESA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79283491A | 1991-11-15 | 1991-11-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL103710A0 IL103710A0 (en) | 1993-04-04 |
| IL103710A true IL103710A (en) | 1998-02-08 |
Family
ID=25158215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL103710A IL103710A (en) | 1991-11-15 | 1992-11-11 | R(-)-enantiomers of n-trityl- 4-oxo-5-phosphonovalinate derivatives |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0613459B1 (ja) |
| JP (1) | JP3168563B2 (ja) |
| KR (1) | KR100241480B1 (ja) |
| AT (1) | ATE134989T1 (ja) |
| AU (1) | AU667845B2 (ja) |
| CA (1) | CA2121835A1 (ja) |
| DE (1) | DE69208888T2 (ja) |
| DK (1) | DK0613459T3 (ja) |
| ES (1) | ES2087555T3 (ja) |
| FI (1) | FI942248A0 (ja) |
| GR (1) | GR3019587T3 (ja) |
| HU (1) | HU214055B (ja) |
| IL (1) | IL103710A (ja) |
| MX (1) | MX9206448A (ja) |
| NO (1) | NO305314B1 (ja) |
| WO (1) | WO1993010075A1 (ja) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2025326C (en) * | 1989-09-19 | 2001-04-24 | Jeffrey P. Whitten | Nmda antagonists |
-
1992
- 1992-10-13 ES ES92921774T patent/ES2087555T3/es not_active Expired - Lifetime
- 1992-10-13 DK DK92921774.3T patent/DK0613459T3/da active
- 1992-10-13 AT AT92921774T patent/ATE134989T1/de not_active IP Right Cessation
- 1992-10-13 JP JP50924593A patent/JP3168563B2/ja not_active Expired - Fee Related
- 1992-10-13 WO PCT/US1992/008739 patent/WO1993010075A1/en active IP Right Grant
- 1992-10-13 CA CA002121835A patent/CA2121835A1/en not_active Abandoned
- 1992-10-13 AU AU28642/92A patent/AU667845B2/en not_active Ceased
- 1992-10-13 EP EP92921774A patent/EP0613459B1/en not_active Expired - Lifetime
- 1992-10-13 HU HU9401469A patent/HU214055B/hu not_active IP Right Cessation
- 1992-10-13 DE DE69208888T patent/DE69208888T2/de not_active Expired - Fee Related
- 1992-10-13 KR KR1019940701634A patent/KR100241480B1/ko not_active IP Right Cessation
- 1992-11-10 MX MX9206448A patent/MX9206448A/es not_active IP Right Cessation
- 1992-11-11 IL IL103710A patent/IL103710A/en not_active IP Right Cessation
-
1994
- 1994-05-13 FI FI942248A patent/FI942248A0/fi unknown
- 1994-05-13 NO NO941820A patent/NO305314B1/no not_active IP Right Cessation
-
1996
- 1996-04-09 GR GR960400979T patent/GR3019587T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0613459A1 (en) | 1994-09-07 |
| HU214055B (en) | 1997-12-29 |
| DE69208888T2 (de) | 1996-08-01 |
| MX9206448A (es) | 1993-05-01 |
| ATE134989T1 (de) | 1996-03-15 |
| IL103710A0 (en) | 1993-04-04 |
| ES2087555T3 (es) | 1996-07-16 |
| HUT70551A (en) | 1995-10-30 |
| CA2121835A1 (en) | 1993-05-27 |
| DK0613459T3 (da) | 1996-04-01 |
| NO941820D0 (no) | 1994-05-13 |
| DE69208888D1 (de) | 1996-04-11 |
| NO941820L (no) | 1994-05-13 |
| FI942248A (fi) | 1994-05-13 |
| WO1993010075A1 (en) | 1993-05-27 |
| KR100241480B1 (ko) | 2000-03-02 |
| FI942248A0 (fi) | 1994-05-13 |
| GR3019587T3 (en) | 1996-07-31 |
| AU2864292A (en) | 1993-06-15 |
| HU9401469D0 (en) | 1994-08-29 |
| NO305314B1 (no) | 1999-05-10 |
| EP0613459B1 (en) | 1996-03-06 |
| JP3168563B2 (ja) | 2001-05-21 |
| JPH07501523A (ja) | 1995-02-16 |
| AU667845B2 (en) | 1996-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5146965B2 (ja) | 不純物を含まない非晶質ロスバスタチンカルシウムの調製方法 | |
| JP2009542676A (ja) | ヒンバシン類似体の合成において使用される｛［５−（３−フルオロフェニル）−ピリジン−２−イル］メチル｝ホスホン酸ジエチルの合成 | |
| JPH05500949A (ja) | ｇｅｍ―ジホスホン酸、その製造法、およびそれを含む医薬組成物 | |
| JP2869572B2 (ja) | ホスファチジルコリン誘導体の製造方法 | |
| KR100926844B1 (ko) | 스핑고신의 합성을 위한 제조방법 | |
| JP2716746B2 (ja) | ホスフィン酸類 | |
| EP0613459B1 (en) | N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists | |
| US5554773A (en) | N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists | |
| JP4278859B2 (ja) | オキサアザホスホリン−２−アミンの製造方法 | |
| JPS5936914B2 (ja) | セフアロスポリン類縁体 | |
| IE910047A1 (en) | The diastereoselective preparation of phosphinate esters | |
| RU2205834C2 (ru) | Способ получения [2-((8,9)-диоксо-2,6-диазобицикло-[5.2.0]нон-1(7)-ен-2-ил)этил]фосфоновой кислоты, способ получения ди-с1-с6-алкилового эфира n-[3-(трет-бутилоксикарбониламино)пропил]-2-аминоэтилфосфорной кислоты, соединения | |
| KR101195631B1 (ko) | ９-［２-(포스포노메톡시)에틸］아데닌의 개선된 제조방법 | |
| JP2008526908A (ja) | 有用な二置換アミンの新規な一段合成法 | |
| JP3157262B2 (ja) | 新規オキサゾリジノン誘導体 | |
| JP4070608B2 (ja) | 光学的に活性なジヒドロピロンの製造方法 | |
| KR100472048B1 (ko) | 아즈트레오남의 신규제조방법 | |
| EP1673377B1 (en) | Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives | |
| JP3494465B2 (ja) | 光学活性α−アミノ酸誘導体の製造方法 | |
| JP3185946B2 (ja) | γ，δ−不飽和−β−アミノ酸誘導体及びその製造方法 | |
| HU207711B (en) | Process for producing glutaric acid derivatives | |
| JP4244364B2 (ja) | 光学活性スルフォスチン及びその類縁体の製造における光学活性中間体の製造方法 | |
| JP3719269B2 (ja) | ２−アルキル−４−オキソ−５、６、７、８−テトラヒドロ−シクロヘプトイミダゾールの製造方法 | |
| US20020165269A1 (en) | Process for preparing optically active dihydropyrones | |
| JPH09241266A (ja) | ビス−テトラヒドロフラン誘導体の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH1 | Patent not in force | ||
| HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PARMACEUTICALS, INC. |